Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Evaluation of C-reactive protein as an inflammatory biomarker in rabbits for vaccine nonclinical safety studies.

Destexhe E, Prinsen MK, van Schöll I, Kuper CF, Garçon N, Veenstra S, Segal L.

J Pharmacol Toxicol Methods. 2013 Nov-Dec;68(3):367-73. doi: 10.1016/j.vascn.2013.04.003. Epub 2013 Apr 23.

PMID:
23624216
2.

Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine.

Faingezicht I, Avila-Aguerro ML, Cervantes Y, Fourneau M, Clemens SA.

Rev Panam Salud Publica. 2002 Oct;12(4):247-57.

PMID:
12431356
3.

The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.

Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.

Int J Infect Dis. 2008 May;12(3):278-88. Epub 2007 Nov 5.

6.

Comparison of the adjuvanticity of aluminum salts and their combination in hepatitis B recombinant protein vaccine in assessed mice.

Mahboubi A, Fazeli MR, Dinarvand R, Samadi N, Sharifzadeh M, Ilka H, Azadi S, Soleimanian R, Kalkouei H, Hajikhanmirzaei R, Valadkhani M.

Iran J Immunol. 2008 Sep;5(3):163-70. doi: IJIv5i3A4.

PMID:
18791283
7.

A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America.

Tregnaghi M, López P, Rocha C, Rivera L, David MP, Rüttimann R, Schuerman L.

Rev Panam Salud Publica. 2006 Mar;19(3):179-88.

PMID:
16640847
8.

Long-term antibody persistence after booster vaccination with combined tetravalent diphtheria tetanus, whole-cell Bordetella pertussis and hepatitis B vaccine in healthy infants.

Poovorawan Y, Theamboonlers A, Sanpavat S, Chumdermpadetsuk S, Safary A, Vandepapeliere P.

Ann Trop Paediatr. 1997 Dec;17(4):301-8.

PMID:
9578788
9.

Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants.

Kanra G, Kara A, Demiralp O, Contorni M, Hilbert AK, Spyr C, Viviani S.

Hum Vaccin. 2006 Jul-Aug;2(4):155-60. Epub 2006 Jul 21.

PMID:
17012890
11.

A new DTPw-HBV/Hib vaccine: immune memory after primary vaccination and booster dosing in the second year of life.

Gatchalian S, Reyes M, Bermal N, Chandrasekaran V, Han HH, Bock HL, Lefevre I.

Hum Vaccin. 2008 Jan-Feb;4(1):60-6. Epub 2007 Sep 23.

PMID:
18376148
12.

Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.

Knuf M, Habermehl P, Faber J, Bock HL, Sänger R, Bogaerts H, Clemens R, Schuind A, du Prel JB, Schmitt HJ.

Vaccine. 2006 Jul 7;24(27-28):5627-36. Epub 2006 May 2.

PMID:
16740348
13.

Immunogenicity and reactogenicity of DTPw-HB/Hib vaccine administered to colombian infants after a birth dose of hepatitis B vaccine.

López P, Rubiano L, del Pilar Rubio M, David MP, Safary A.

Expert Rev Vaccines. 2002 Oct;1(3):277-83.

PMID:
12901568
14.

A new DTPw-HBV/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.

Gatchalian S, Reyes M, Bernal N, Lefevre I, David MP, Han HH, Bock HL, Wolter J, Schuerman L.

Hum Vaccin. 2005 Sep-Oct;1(5):198-203. Epub 2005 Sep 7.

PMID:
17012860
15.

Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia.

Wong SL, Soosai P, Teoh YL, Han HH, Lefevre I, Bock HL.

Southeast Asian J Trop Med Public Health. 2008 May;39(3):474-83.

PMID:
18564687
17.

Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine.

Arístegui J, Usonis V, Coovadia H, Riedemann S, Win KM, Gatchalian S, Bock HL.

Int J Infect Dis. 2003 Jun;7(2):143-51.

PMID:
12839717
18.

The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants.

Prymula R, David MP, Lefevre I, Kohl I, Stefkovicová M.

Hum Vaccin. 2007 Jul-Aug;3(4):121-6. Epub 2007 Feb 28.

PMID:
17404515
19.

New hepatitis B vaccine formulated with an improved adjuvant system.

Kundi M.

Expert Rev Vaccines. 2007 Apr;6(2):133-40. Review.

PMID:
17408363
20.

Immunogenicity of two diphtheria-tetanus-whole cell pertussis-hepatitis B vaccines in infants: a comparative trial.

Kulkarni PS, Sapru A, Bavdekar A, Naik SS, Patwardhan M, Barde P, Pandit AN.

Hum Vaccin. 2011 Sep;7(9):941-4. doi: 10.4161/hv.7.9.15994. Epub 2011 Sep 1.

PMID:
21921700

Supplemental Content

Support Center